Search

everythinglearnresearchcommunity

for

Search:↓

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

Effective treatments for severe alopecia areata are still lacking.

Indian dermatosurgical practitioners were given guidelines in 2011 to reduce infection risks, including hand hygiene, sterilization methods, operation theater standards, and proper waste disposal.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Niosomes are a promising and effective way to deliver drugs through the skin.

New treatments for lupus show promise, but more research is needed, especially for children.

FUT effectively treats male-pattern hair loss with high satisfaction.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Advancements in hair transplantation have resulted in more natural-looking hair and increased patient satisfaction.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.